BACE1 and BACE2: exclusion of allele association with Alzheimer's disease

被引：0
|
作者：
Giannakopoulos, P
Herrmann, F
Gold, G
Bouras, C
Mulligan, R
Duriaux-Sail, G
Michon, A
Antonarakis, SE
Blouin, JL
机构：
[1] Univ Hosp Geneva, Dept Psychiat & Genet, Geneva, Switzerland
[2] Univ Geneva, Sch Med, CH-1211 Geneva, Switzerland
来源：
EUROPEAN JOURNAL OF HUMAN GENETICS | 2002年 / 10卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：267 / 267
页数：1
相关论文
共 50 条
  • [41] BACE1 inhibition as a therapeutic strategy for Alzheimer's disease
    Vassar, Robert
    Journal of Sport and Health Science, 2016, 5 (04) : 388 - 390
  • [42] BACE1 expression and activity: Relevance in Alzheimer's disease
    Zacchetti, Daniele
    Chieregatti, Evelina
    Bettegazzi, Barbara
    Mihailovich, Marija
    Sousa, Vitor Lino
    Grohovaz, Fabio
    Meldolesi, Jacopo
    NEURODEGENERATIVE DISEASES, 2007, 4 (2-3) : 117 - 126
  • [43] β-Secretase activity in rat astrocytes: translational block of BACE1 and modulation of BACE2 expression
    Bettegazzi, Barbara
    Mihailovich, Marija
    Di Cesare, Alessandra
    Consonni, Alessandra
    Macco, Romina
    Pelizzoni, Ilaria
    Codazzi, Franca
    Grohovaz, Fabio
    Zacchetti, Daniele
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2011, 33 (02) : 236 - 243
  • [44] BACE1 gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease
    Sjolander, Annica
    Zetterberg, Henrik
    Andreasson, Ulf
    Minthon, Lennart
    Blennow, Kaj
    MOLECULAR NEURODEGENERATION, 2010, 5
  • [45] RNAi inhibition of BACE1 and BACE2 expression in HEK293-APPSWE/LON cells identifies a dominant role for BACE1 in APP processing
    Chen, X
    Wang, LY
    Kennedy, ME
    NEUROBIOLOGY OF AGING, 2004, 25 : S532 - S532
  • [46] Presence of BACE1 and BACE2 in muscle fibres of patients with sporadic inclusion-body myositis
    Vattemi, G
    Engel, WK
    McFerrin, J
    Buxbaum, JD
    Pastorino, L
    Askanas, V
    LANCET, 2001, 358 (9297): : 1962 - 1964
  • [47] 1,3-Oxazines as BACE1 and/or BACE2 inhibitors: a patent evaluation (WO2012156284)
    Gilbert, Eric J.
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2013, 23 (08) : 1069 - 1073
  • [48] BACE1 inhibitor drugs in clinical trials for Alzheimer’s disease
    Robert Vassar
    Alzheimer's Research & Therapy, 6
  • [49] Beta-secretase (BACE1) inhibitors for Alzheimer's disease
    Butler, Christopher
    Brodney, Michael
    Ogilvie, Kevin
    Martinez-Alsina, Luis
    Helal, Christopher
    Nolan, Charles
    Parris, Kevin
    Vajdos, Felix
    Gonzales, Cathleen
    Robshaw, Ashley
    Doran, Shawn
    Beck, Elizabeth
    Barreiro, Gabriela
    Riddell, David
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [50] A Close Look at BACE1 Inhibitors for Alzheimer’s Disease Treatment
    Brati Das
    Riqiang Yan
    CNS Drugs, 2019, 33 : 251 - 263
12345